NASDAQ:BCYC Bicycle Therapeutics (BCYC) Insider Trading & Ownership $20.17 +0.02 (+0.10%) (As of 03:07 PM ET) Add Compare Share Share Today's Range$20.09▼$21.1250-Day Range$20.09▼$25.8252-Week Range$18.84▼$33.49Volume110,297 shsAverage Volume285,711 shsMarket Capitalization$605.91 millionP/E RatioN/ADividend YieldN/APrice Target$48.75 Insider TradesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Bicycle Therapeutics (NASDAQ:BCYC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.20%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$393,802.64 Get BCYC Insider Trade Alerts Want to know when executives and insiders are buying or selling Bicycle Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BCYC Insider Buying and Selling by Quarter Bicycle Therapeutics Insider and Congressional Trades History Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails7/3/2023Kevin LeeCEOSell1,498$25.10$37,599.80323,601 7/3/2023Michael SkynnerCTOSell451$25.10$11,320.1070,924 7/3/2023Nicholas KeenInsiderSell336$25.10$8,433.6038,505 7/3/2023Travis Alvin ThompsonCAOSell61$25.10$1,531.108,033 4/3/2023Kevin LeeCEOSell1,486$21.11$31,369.46325,099 4/3/2023Lee KalowskiCFOSell376$21.11$7,937.3630,309 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/3/2023Michael SkynnerCTOSell447$21.11$9,436.1771,375 4/3/2023Nicholas KeenInsiderSell319$21.11$6,734.0938,841 1/3/2023Kevin LeeCEOSell6,000$29.06$174,360.00326,585 1/3/2023Lee KalowskiCFOSell1,815$29.06$52,743.9030,685 1/3/2023Nigel CrockettInsiderSell1,801$29.06$52,337.0630,699 (Data available from 1/1/2013 forward) BCYC Insider Trading Activity - Frequently Asked Questions Who is on Bicycle Therapeutics's Insider Roster? The list of insiders at Bicycle Therapeutics includes Kate Bingham, Kevin Lee, Lee Kalowski, Michael Skynner, Nicholas Keen, Nigel Crockett, Pierre Legault, and Travis Alvin Thompson. Learn more on insiders at BCYC. What percentage of Bicycle Therapeutics stock is owned by insiders? 10.20% of Bicycle Therapeutics stock is owned by insiders. Learn more on BCYC's insider holdings. Which Bicycle Therapeutics insiders have been selling company stock? The following insiders have sold BCYC shares in the last 24 months: Kevin Lee ($793,529.26), Lee Kalowski ($60,681.26), Michael Skynner ($20,756.27), Nicholas Keen ($15,167.69), Nigel Crockett ($52,337.06), Pierre Legault ($2,543,508.07), and Travis Alvin Thompson ($1,531.10). How much insider selling is happening at Bicycle Therapeutics? Insiders have sold a total of 68,807 Bicycle Therapeutics shares in the last 24 months for a total of $3,487,510.71 sold. More Insider Trading Tools from MarketBeat Related Companies: Phathom Pharmaceuticals Insider Buying ARS Pharmaceuticals Insider Buying Tyra Biosciences Insider Buying Avid Bioservices Insider Buying Centessa Pharmaceuticals Insider Buying Dyne Therapeutics Insider Buying RAPT Therapeutics Insider Buying Enliven Therapeutics Insider Buying Genelux Insider Buying Avidity Biosciences Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insiders and Institutions are Scooping Up SelectQuoteInstitutions and Insiders Are Gobbling Up Shares of HASIInsiders Are Buying These 2 Stocks3 Health Companies with Healthy Insider Buying and Market Support2 Cheap Stocks The Insiders Are Buying This page (NASDAQ:BCYC) was last updated on 9/26/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bicycle Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.